Wave Life Sciences Ltd. (WVE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 842 |
| % of all portfolios: | 0.021% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
6 |
$82,561,066 |
| Sells |
43 |
$16,046,535 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 30 Mar 2026 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
30 Mar 2026 |
971,091 |
6.50 |
6,312,092 |
| 30 Mar 2026 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
27 Mar 2026 |
2,495,623 |
6.43 |
16,046,856 |
| 30 Mar 2026 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
26 Mar 2026 |
4,954,558 |
6.06 |
30,024,621 |
| 30 Mar 2026 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
26 Mar 2026 |
351,224 |
6.38 |
2,240,809 |
| 15 Dec 2025 |
GSK PLC |
10% |
11 Dec 2025 |
1,470,000 |
19.00 |
27,930,000 |
| 14 Nov 2025 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
13 Nov 2025 |
1,000 |
6.69 |
6,688 |
| 01 Oct 2024 |
GSK PLC |
10% |
27 Sep 2024 |
2,791,930 |
8.00 |
22,335,440 |
| 30 Jan 2024 |
GSK PLC |
10% |
07 Dec 2023 |
3,300,000 |
5.00 |
16,500,000 |
| 13 Dec 2023 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
11 Dec 2023 |
1,000,000 |
5.00 |
5,000,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock